Considerations for comprehensive assessment of genetic predisposition in familial breast cancer

Henry T. Lynch, Carrie Synder, San Ming Wang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

About 10-15% of breast cancer cases are family related, classified as familial breast cancer. The disease was first reported in 1866 and determined to be an autosomal dominant genetic disease in 1971. Germline mutations in BRCA1 were discovered and deemed as the first genetic predisposition for the disease in 1994. By now, genetic predispositions for about 40% of familial breast cancer families have been identified. New molecular genetic approaches currently under development should accelerate the process to identify the full spectrum of genetic predispositions for the disease, thereby enabling a better understanding of the genetic basis of the disease and therein providing benefit to high-risk patients.

Original languageEnglish
Pages (from-to)67-75
Number of pages9
JournalBreast Journal
Volume21
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Inborn Genetic Diseases
Genetic Predisposition to Disease
Germ-Line Mutation
Molecular Biology
Breast Neoplasms
Familial Breast Cancer

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Oncology
  • Surgery
  • Medicine(all)

Cite this

Considerations for comprehensive assessment of genetic predisposition in familial breast cancer. / Lynch, Henry T.; Synder, Carrie; Wang, San Ming.

In: Breast Journal, Vol. 21, No. 1, 01.01.2015, p. 67-75.

Research output: Contribution to journalArticle

@article{ca5fc7714cc24cf398cabc431432c86a,
title = "Considerations for comprehensive assessment of genetic predisposition in familial breast cancer",
abstract = "About 10-15{\%} of breast cancer cases are family related, classified as familial breast cancer. The disease was first reported in 1866 and determined to be an autosomal dominant genetic disease in 1971. Germline mutations in BRCA1 were discovered and deemed as the first genetic predisposition for the disease in 1994. By now, genetic predispositions for about 40{\%} of familial breast cancer families have been identified. New molecular genetic approaches currently under development should accelerate the process to identify the full spectrum of genetic predispositions for the disease, thereby enabling a better understanding of the genetic basis of the disease and therein providing benefit to high-risk patients.",
author = "Lynch, {Henry T.} and Carrie Synder and Wang, {San Ming}",
year = "2015",
month = "1",
day = "1",
doi = "10.1111/tbj.12358",
language = "English",
volume = "21",
pages = "67--75",
journal = "Breast Journal",
issn = "1075-122X",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Considerations for comprehensive assessment of genetic predisposition in familial breast cancer

AU - Lynch, Henry T.

AU - Synder, Carrie

AU - Wang, San Ming

PY - 2015/1/1

Y1 - 2015/1/1

N2 - About 10-15% of breast cancer cases are family related, classified as familial breast cancer. The disease was first reported in 1866 and determined to be an autosomal dominant genetic disease in 1971. Germline mutations in BRCA1 were discovered and deemed as the first genetic predisposition for the disease in 1994. By now, genetic predispositions for about 40% of familial breast cancer families have been identified. New molecular genetic approaches currently under development should accelerate the process to identify the full spectrum of genetic predispositions for the disease, thereby enabling a better understanding of the genetic basis of the disease and therein providing benefit to high-risk patients.

AB - About 10-15% of breast cancer cases are family related, classified as familial breast cancer. The disease was first reported in 1866 and determined to be an autosomal dominant genetic disease in 1971. Germline mutations in BRCA1 were discovered and deemed as the first genetic predisposition for the disease in 1994. By now, genetic predispositions for about 40% of familial breast cancer families have been identified. New molecular genetic approaches currently under development should accelerate the process to identify the full spectrum of genetic predispositions for the disease, thereby enabling a better understanding of the genetic basis of the disease and therein providing benefit to high-risk patients.

UR - http://www.scopus.com/inward/record.url?scp=84920886118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920886118&partnerID=8YFLogxK

U2 - 10.1111/tbj.12358

DO - 10.1111/tbj.12358

M3 - Article

C2 - 25472498

AN - SCOPUS:84920886118

VL - 21

SP - 67

EP - 75

JO - Breast Journal

JF - Breast Journal

SN - 1075-122X

IS - 1

ER -